文献速递糖尿病肥胖与代谢综合征

FDG PET测量肝脏葡萄糖摄取的研究进展与挑战:对糖尿病研究的意义

Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research.
PubMed 文献 · Diabetologia · 2023-12-15

本文综述利用[18F]-2-氟-2-脱氧-D-葡萄糖(FDG)PET测量肝脏葡萄糖摄取(HGU)的现有方案及知识现状,讨论HGU在2型糖尿病中的受损情况。动态成像可能优于静态成像,FDG PET联合胰岛素刺激对测量组织特异性胰岛素敏感性至关重要。现有方法潜力大,但需更系统利用以理解代谢疾病机制,尚需进一步研究。

要点

  • HGU受血糖、胰岛素、胰高血糖素等多变量影响,评估时需根据研究问题审慎选择代谢状态。
  • 动态成像可提供详细动力学信息和流入速率,可能优于静态成像。
  • FDG PET联合胰岛素刺激对测量组织特异性胰岛素敏感性至关重要。

核心结论

  • 现有HGU测量方法潜力大,但需更系统利用以理解代谢疾病机制。
  • FDG PET研究HGU的现有发现提示2型糖尿病和肥胖中胰岛素抵抗、肝脏葡萄糖代谢、NEFA水平和肝内脂质积累之间存在复杂相互作用。
  • 尚需进一步研究以充分理解这些情况下改善HGU的潜在机制和治疗靶点。

研究设计与样本

  • 本文为综述,提供FDG PET测量HGU的可用方案,并讨论HGU及其在2型糖尿病中受损的当前知识现状。

主要发现

  • 动态成像可测量详细动力学信息和流入速率,可能优于静态成像。
  • FDG PET联合胰岛素刺激对测量组织特异性胰岛素敏感性至关重要。
  • 高胰岛素-正常血糖钳夹可在受控血糖水平下标准化测量,但部分研究问题可能需要口服葡萄糖负荷等更生理性的方法,其优缺点与血糖和胰岛素水平波动相关。

关键数值与推荐

  • HGU通过[18F]-2-氟-2-脱氧-D-葡萄糖(FDG)PET显像测量。
  • HGU评估的代谢状态应根据研究问题审慎选择并保持一致。
  • 方案和测量条件需标准化以获得可重复结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The liver plays a crucial role in the control of glucose homeostasis and is therefore of great interest in the investigation of the development of type 2 diabetes. Hepatic glucose uptake (HGU) can be measured through positron emission tomography (PET) imaging with the tracer [18F]-2-fluoro-2-deoxy-D-glucose (FDG). HGU is dependent on many variables (e.g. plasma glucose, insulin and glucagon concentrations), and the metabolic state for HGU assessment should be chosen with care and coherence with the study question. In addition, as HGU is influenced by many factors, protocols and measurement conditions need to be standardised for reproducible results. This review provides insights into the protocols that are available for the measurement of HGU by FDG PET and discusses the current state of knowledge of HGU and its impairment in type 2 diabetes. Overall, a scanning modality that allows for the measurement of detailed kinetic information and influx rates (dynamic imaging) may be preferable to static imaging. The combination of FDG PET and insulin stimulation is crucial to measure tissue-specific insulin sensitivity. While the hyperinsulinaemic-euglycaemic clamp allows for standardised measurements under controlled blood glucose levels, some research questions might require a more physiological approach, such as oral glucose loading, with both advantages and complexities relating to fluctuations in blood glucose and insulin levels. The available approaches to address HGU hold great potential but await more systematic exploitation to improve our understanding of the mechanisms underlying metabolic diseases. Current findings from the investigation of HGU by FDG PET highlight the complex interplay between insulin resistance, hepatic glucose metabolism, NEFA levels and intrahepatic lipid accumulation in type 2 diabetes and obesity. Further research is needed to fully understand the underlying mechanisms and potential therapeutic targets for improving HGU in these conditions.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Basset-Sagarminaga J, van de Weijer T, Iozzo P, et al. Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research. Diabetologia. 2023. PMID: 38099962. doi:10.1007/s00125-023-06055-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。